Cargando…
S224: HIGH COMPLETE RESPONSE RATE WITH TNB-486, A NOVEL CD19XCD3 T-CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428429/ http://dx.doi.org/10.1097/01.HS9.0000967808.60614.fc |
| _version_ | 1785090467121070080 |
|---|---|
| author | Jacobs, Ryan Nair, Ranjit Cho, Seok-Goo Devata, Sumana Gaballa, Sameh Yoon, Dok Hyun Stevens, Don Kim, Jin Seok Shah, Nirav N Brennan, Denise Marie Law, Jason Lesley, Robin Chen, Rob Forcina, Alessandra Buelow, Ben Hou, Jing-Zhou |
| author_facet | Jacobs, Ryan Nair, Ranjit Cho, Seok-Goo Devata, Sumana Gaballa, Sameh Yoon, Dok Hyun Stevens, Don Kim, Jin Seok Shah, Nirav N Brennan, Denise Marie Law, Jason Lesley, Robin Chen, Rob Forcina, Alessandra Buelow, Ben Hou, Jing-Zhou |
| author_sort | Jacobs, Ryan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428429 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284292023-08-17 S224: HIGH COMPLETE RESPONSE RATE WITH TNB-486, A NOVEL CD19XCD3 T-CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY Jacobs, Ryan Nair, Ranjit Cho, Seok-Goo Devata, Sumana Gaballa, Sameh Yoon, Dok Hyun Stevens, Don Kim, Jin Seok Shah, Nirav N Brennan, Denise Marie Law, Jason Lesley, Robin Chen, Rob Forcina, Alessandra Buelow, Ben Hou, Jing-Zhou Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428429/ http://dx.doi.org/10.1097/01.HS9.0000967808.60614.fc Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Jacobs, Ryan Nair, Ranjit Cho, Seok-Goo Devata, Sumana Gaballa, Sameh Yoon, Dok Hyun Stevens, Don Kim, Jin Seok Shah, Nirav N Brennan, Denise Marie Law, Jason Lesley, Robin Chen, Rob Forcina, Alessandra Buelow, Ben Hou, Jing-Zhou S224: HIGH COMPLETE RESPONSE RATE WITH TNB-486, A NOVEL CD19XCD3 T-CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY |
| title | S224: HIGH COMPLETE RESPONSE RATE WITH TNB-486, A NOVEL CD19XCD3 T-CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY |
| title_full | S224: HIGH COMPLETE RESPONSE RATE WITH TNB-486, A NOVEL CD19XCD3 T-CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY |
| title_fullStr | S224: HIGH COMPLETE RESPONSE RATE WITH TNB-486, A NOVEL CD19XCD3 T-CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY |
| title_full_unstemmed | S224: HIGH COMPLETE RESPONSE RATE WITH TNB-486, A NOVEL CD19XCD3 T-CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY |
| title_short | S224: HIGH COMPLETE RESPONSE RATE WITH TNB-486, A NOVEL CD19XCD3 T-CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY |
| title_sort | s224: high complete response rate with tnb-486, a novel cd19xcd3 t-cell engager, in relapsed/refractory follicular lymphoma: interim results from an ongoing phase 1 study |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428429/ http://dx.doi.org/10.1097/01.HS9.0000967808.60614.fc |
| work_keys_str_mv | AT jacobsryan s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT nairranjit s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT choseokgoo s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT devatasumana s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT gaballasameh s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT yoondokhyun s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT stevensdon s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT kimjinseok s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT shahniravn s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT brennandenisemarie s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT lawjason s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT lesleyrobin s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT chenrob s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT forcinaalessandra s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT buelowben s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study AT houjingzhou s224highcompleteresponseratewithtnb486anovelcd19xcd3tcellengagerinrelapsedrefractoryfollicularlymphomainterimresultsfromanongoingphase1study |